N
Patient 1
AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. PATIENT INFORMATION: NO SPECIFIC PATIENT INFORMATION WAS PROVIDED.
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CLINICAL CHEMISTRY CALCIUM | CALCIUM | ABBOTT MANUFACTURING INC | CJY | 03L79-21 | 98314UN17 | Y | Y |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2018-10-25 | 0 |
Patient 1
AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. PATIENT INFORMATION: NO SPECIFIC PATIENT INFORMATION WAS PROVIDED.
Patient 1
THE CUSTOMER REPORTED A FALSELY ELEVATED ARCHITECT CALCIUM RESULT. SAMPLE ID IA0900329SS GENERATED AN INITIAL RESULT OF 10.92 MEQ/L. THE SAMPLE WAS RETESTED MULTIPLE TIMES RANGING FROM 3.51 MEQ/L TO 4.98 MEQ/L. THE CUSTOMER USES A NORMAL RANGE OF 4.09 TO 5.58 MEQ/L. NO SPECIFIC PATIENT INFORMATION WAS PROVIDED. NO ADVERSE IMPACT TO PATIENT MANAGEMENT WAS REPORTED.